Search Results

Laura Bohn’s lab at Scripps Research Institute in Florida. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Prasenjit Saha I conducted my doctoral research at the Indian Institute of Science, Bangalore, India, My research goal is to identify novel cellular target receptors of human gut microbe-derived metabolites During my post-doctoral research, I was part of a study that identified the receptors of a novel human My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

During four years of postdoctoral research at ETH Zurich and the Paul Scherrer Institute in Switzerland Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr. Cell Signaling and Cancer Metastasis Discussion Aurelien Rizk and Yamina Berchiche had a detailed conversation Yamina shared her research experience, emphasizing the fascination of understanding how cells respond to gradients and signals, particularly in relation to cancer metastasis.

Addiction, a multidisciplinary initiative within the University of Minnesota’s Medical School to advance research Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate Slosky’s work has been recognized through several travel and research awards, including the William James In addition to research, Dr. Program and is working to build relationships with key stakeholders through institutional and community

Potent inhibitors of ADO signaling are currently being tested in cancer patients, including in randomized CHUM Research Centre. immunologist, Dr Stagg is recognized for having identified the adenosine-producing enzyme CD73 as a new cancer John Stagg on the web University of Montréal Québec Cancer Consortium The University of Montreal Hospital Research Centre Pubmed LinkedIn Dr.

Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule G Proteins and GPCRs in Cancer Department of Pharmacology, School of Medicine, and Associate Director for Basic Science at the Moores Cancer His research team has pioneered the study of G proteins and G protein coupled receptors (GPCRs) in human Silvio Gutkind on the web Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications Pubmed LinkedIn Twitter UCSD Moores Cancer Center Dr.

GPCR Ecosystem and beyond About Monserrat Avila Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung cancer-mutations in the G-protein-coupled receptor Autoproteolysis-Inducing I am currently a postdoctoral researcher fellow in Dr. Kathleen Caron's laboratory at UNC. My research focuses on understanding the molecular mechanisms of adhesion GPCRs (aGPCRs) in lymphatic

At Monash Institute of Pharmaceutical Sciences, a quiet experiment challenged the traditional PI-silo one could build a fiefdom — and everyone had to talk.” — Michelle Halls This structure: Multiplied research

Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). He has published over 70 research articles, reviews and book chapters on drug discovery, which have been How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

After returning to Germany I set up my own lab at the Institute of Physiology at Würzburg, where I later Leipzig University, where I now head the Department of General Biochemistry at the Rudolf Schönheimer Institute How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

I got my Bachelor's in Pharmacy from Minia University in 2011 and began my career as a teaching and research During my short academic journey, I was awarded the Young Investigator Transdisciplinary Research Award (2022-2023 and 2023-2024) from the bone and joint institute, Western University and the New Student Currently, I am engaged in postdoctoral research in the laboratory of Dr. Scott Prosser. My primary research focus lies in gaining deeper insights into the structural mechanisms governing G

of the most prestigious Clinician Postdoctoral Fellowships offered by Alberta Innovates and Canadian Institutes of Health Research. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Terry Hébert on the web Terry Hébert | Institute of Health Sciences Education Hébert Lab LinkedIn Hébert How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

a molecular pharmacologist at the University of Nottingham, to discuss his scientific journey, GPCR research Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding to cannabinoid receptor research Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions In 2010 he became a group leader at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

highlights the role of interdisciplinary collaboration in accelerating innovation in diabetes and obesity research Originally trained as a Veterinary Surgeon , he completed postdoctoral research at the CNRS in Montpellier He later served as Professor of Cellular Metabolism and Institute Deputy Director at the University of How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

A large component of his work is centered around dysregulated signaling in cancer and the development of novel mechanism-based cancer therapies. Silvio Gutkind on the web Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications More J Silvio Gutkind on LinkedIn Gutkind Lab on Twitter UCSD Moores Cancer Center Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Weill Cornell Graduate School of Medical Sciences in New York City, studying epigenetic changes in cancer During her postdoctoral training at New York University School of Medicine, her research focused on cellular How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

My research aims to understand the mechanisms and consequences cell communication via heterotrimeric Our ongoing efforts have direct implications in cancer, embryonic development defects, and neurological Garcia-Marcos shares insights on transitioning from postdoctoral research to leading his own lab, addressing Garcia-Markos reflects on milestones in his research journey, reinforcing the passion that drives scientists How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Caron on the web UNC-Chapel Hill Department of Cell Biology and Physiology UNC Lineberger Comprehensive Cancer Center Twitter Google Scholar ORCID ResearchGate Dr.

Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

This week's GPCR roll-up includes the latest insights, research discoveries, and advancements. We'll also preview upcoming courses designed for both experienced researchers and newcomers. 🚀 Develop Conformational Landscapes Rajan Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Cortical astrocyte activation triggers meningeal nociception and migraine-like pain GPCRs in Oncology and Immunology mediators of tumour-to-TME crosstalk Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer

GPCR to connect with the researchers who need them most. ✳️ Learn more about the partnership: https:/ /www.ecosystem.drgpcr.com/celtarys-research-dr-gpcr-ecosystem #GPCRcommunity #ScienceCollaboration #FluorescentLigands GPCR to connect with the researchers who need them most. ✳️ Learn more about the partnership: https:/ /www.ecosystem.drgpcr.com/celtarys-research-dr-gpcr-ecosystem #GPCRcommunity #ScienceCollaboration #FluorescentLigands

of the most prestigious Clinician Postdoctoral Fellowships offered by Alberta Innovates and Canadian Institutes of Health Research.

Listen to other scientists’ research—it’s a great way to stay motivated and inspired 🚀 Don’t miss this ✅ https://buff.ly/FTB69y9 #GPCR #DrGPCR #SciencePodcast #Pharmacology #CancerResearch Published on April Listen to other scientists’ research—it’s a great way to stay motivated and inspired 🚀 Don’t miss this ✅ https://buff.ly/FTB69y9 #GPCR #DrGPCR #SciencePodcast #Pharmacology #CancerResearch Previous Next Recent

Known for their fluorescent ligand innovation, Celtarys is helping researchers make biology visible, GPCR Ecosystem: https://www.ecosystem.drgpcr.com/celtarys-research-dr-gpcr-ecosystem #DrGPCR #GPCRtools Known for their fluorescent ligand innovation, Celtarys is helping researchers make biology visible, GPCR Ecosystem: https://www.ecosystem.drgpcr.com/celtarys-research-dr-gpcr-ecosystem #DrGPCR #GPCRtools

GPCRs are among the most powerful and complex targets in biomedical research. She has been leading collaborative projects with public research institutes and pharmaceutical companies , most notably the joint Revvity/Institute of Functional Genomics team, EIDOS. In 2020, together with her team, she initiated a long-term research effort that enabled the creation Eric Trinquet, Director of Research and Development at Revvity.

He earned his Ph.D. at the Massachusetts Institute of Technology, where he studied MHC class II structure-function How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Sri previously worked at the Wyss Institute and Harvard, where he built numerous technologies in gene How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation Now at the University of Glasgow, his primary research interests are focused on the rational design of In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating research. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research